Veterinary Active Pharmaceutical Ingredients Manufacturing - Global and China Top Players Market Share and Ranking 2024
The market is primarily driven by the growing demand for veterinary drugs owing to the rising prevalence of zoonotic diseases, the increasing number of veterinary pharmaceutical players, and the growing animal population, pet ownership, pet humanization & pet expenditure.
This report studies and analyses global Veterinary Active Pharmaceutical Ingredients Manufacturing status and future trends, helps the client to determine the Veterinary Active Pharmaceutical Ingredients Manufacturing market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Veterinary Active Pharmaceutical Ingredients Manufacturing, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Veterinary Active Pharmaceutical Ingredients Manufacturing market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Veterinary Active Pharmaceutical Ingredients Manufacturing sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Veterinary Active Pharmaceutical Ingredients Manufacturing sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Veterinary Active Pharmaceutical Ingredients Manufacturing key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Veterinary Active Pharmaceutical Ingredients Manufacturing key producing regions, capacity, production, and year over year growth
(6) Veterinary Active Pharmaceutical Ingredients Manufacturing industry chains, upstream, midstream and downstream
According to latest study, the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Veterinary Active Pharmaceutical Ingredients Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Veterinary Active Pharmaceutical Ingredients Manufacturing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Companion Animals grew percent to account for percent of the total market sales, and Production/Food Animals grew percent.
Market segment by players, this report covers
Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Chempro Pharma Private Ltd.
Menadiona
SUANFARMA
Vetpharma (Insud Pharma, S.L.U)
Siflon Drugs
Qilu Pharma
FIS - Fabbrica Italiana Sintetici S.p.A.
Market segment by Type, covers
Antiparasitic
Anti-infectives
NSAIDs
Others
Market segment by Application, can be divided into
Companion Animals
Production/Food Animals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Veterinary Active Pharmaceutical Ingredients Manufacturing product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Veterinary Active Pharmaceutical Ingredients Manufacturing market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Veterinary Active Pharmaceutical Ingredients Manufacturing market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Veterinary Active Pharmaceutical Ingredients Manufacturing, percent & CAGR, 2018-2029
Chapter 5: Veterinary Active Pharmaceutical Ingredients Manufacturing industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Definition
1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Forecast
1.2.1 By Consumption Value, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size，2018-2029
1.2.2 By Sales Quantity, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size，2018-2029
1.2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP)，2018-2029
1.3 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Forecast
1.3.1 By Consumption Value, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size，2018-2029
1.3.2 By Sales Quantity, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size，2018-2029
1.3.3 China Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP)， 2018-2029
1.4 Share of China Veterinary Active Pharmaceutical Ingredients Manufacturing Market with Respect to the Global Market
1.4.1 By Consumption Value, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share in Global, 2018-2029
1.4.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size: China VS Global, 2018-2029
1.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
1.5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers
1.5.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
1.5.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
1.5.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Veterinary Active Pharmaceutical Ingredients Manufacturing, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Veterinary Active Pharmaceutical Ingredients Manufacturing, Global Market Share by Company, 2018-2023
2.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Concentration Ratio
2.6 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Mergers & Acquisitions, Expansion Plans
2.7 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Product Type
2.8 Head Office and Veterinary Active Pharmaceutical Ingredients Manufacturing Production Site of Key Manufacturer
2.9 Veterinary Active Pharmaceutical Ingredients Manufacturing Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Veterinary Active Pharmaceutical Ingredients Manufacturing, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Veterinary Active Pharmaceutical Ingredients Manufacturing, China Market Share by Company, 2018-2023
3.3 China Veterinary Active Pharmaceutical Ingredients Manufacturing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Capacity by Region
4.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Production by Region, 2018-2029
4.5 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain
5.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Upstream Analysis
5.2.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Core Raw Materials
5.2.2 Main Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Production Mode
5.6 Veterinary Active Pharmaceutical Ingredients Manufacturing Procurement Model
5.7 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Sales Model and Sales Channels
5.7.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Model
5.7.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Distributors
6 Sights by Type
6.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Classification
6.1.1 Antiparasitic
6.1.2 Anti-infectives
6.1.3 NSAIDs
6.1.4 Others
6.2 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029
6.4 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029
6.5 By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Application
7.1.1 Companion Animals
7.1.2 Production/Food Animals
7.2 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029
7.4 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029
7.5 By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029
8.3 By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing & Forecasts, 2018-2029
8.4.2 By Country, North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
8.5 Europe
8.5.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
8.7 South America
8.7.1 South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029
9.3 By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
9.4.2 By Type, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
9.5.2 By Type, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
9.6.2 By Type, China Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
9.7.2 By Type, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
9.8.2 By Type, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
9.10.2 By Type, India Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Alivira Animal Health Ltd.
10.1.1 Alivira Animal Health Ltd. Company Information, Head Office, Market Area, and Industry Position
10.1.2 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Alivira Animal Health Ltd. Company Profile and Main Business
10.1.5 Alivira Animal Health Ltd. Recent Developments
10.2 Excel Industries Ltd.
10.2.1 Excel Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
10.2.2 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.2.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Excel Industries Ltd. Company Profile and Main Business
10.2.5 Excel Industries Ltd. Recent Developments
10.3 Ofichem Group
10.3.1 Ofichem Group Company Information, Head Office, Market Area, and Industry Position
10.3.2 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.3.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Ofichem Group Company Profile and Main Business
10.3.5 Ofichem Group Recent Developments
10.4 Chempro Pharma Private Ltd.
10.4.1 Chempro Pharma Private Ltd. Company Information, Head Office, Market Area, and Industry Position
10.4.2 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.4.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Chempro Pharma Private Ltd. Company Profile and Main Business
10.4.5 Chempro Pharma Private Ltd. Recent Developments
10.5 Menadiona
10.5.1 Menadiona Company Information, Head Office, Market Area, and Industry Position
10.5.2 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.5.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Menadiona Company Profile and Main Business
10.5.5 Menadiona Recent Developments
10.6 SUANFARMA
10.6.1 SUANFARMA Company Information, Head Office, Market Area, and Industry Position
10.6.2 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.6.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 SUANFARMA Company Profile and Main Business
10.6.5 SUANFARMA Recent Developments
10.7 Vetpharma (Insud Pharma, S.L.U)
10.7.1 Vetpharma (Insud Pharma, S.L.U) Company Information, Head Office, Market Area, and Industry Position
10.7.2 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.7.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Vetpharma (Insud Pharma, S.L.U) Company Profile and Main Business
10.7.5 Vetpharma (Insud Pharma, S.L.U) Recent Developments
10.8 Siflon Drugs
10.8.1 Siflon Drugs Company Information, Head Office, Market Area, and Industry Position
10.8.2 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.8.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Siflon Drugs Company Profile and Main Business
10.8.5 Siflon Drugs Recent Developments
10.9 Qilu Pharma
10.9.1 Qilu Pharma Company Information, Head Office, Market Area, and Industry Position
10.9.2 Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.9.3 Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Qilu Pharma Company Profile and Main Business
10.9.5 Qilu Pharma Recent Developments
10.10 FIS - Fabbrica Italiana Sintetici S.p.A.
10.10.1 FIS - Fabbrica Italiana Sintetici S.p.A. Company Information, Head Office, Market Area, and Industry Position
10.10.2 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application
10.10.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 FIS - Fabbrica Italiana Sintetici S.p.A. Company Profile and Main Business
10.10.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million_x000D_
Table 2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints_x000D_
Table 3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends_x000D_
Table 4. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Policy_x000D_
Table 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022_x000D_
Table 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Share by Company, 2018-2023, Ranked by Data of 2022_x000D_
Table 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022_x000D_
Table 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity by Company, 2018-2023, Ranked by Data of 2022_x000D_
Table 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)_x000D_
Table 10. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Market Concentration Ratio (CR3 and HHI)_x000D_
Table 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Mergers & Acquisitions, Expansion Plans_x000D_
Table 12. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Product Type_x000D_
Table 13. Head Office and Veterinary Active Pharmaceutical Ingredients Manufacturing Production Site of Key Manufacturer_x000D_
Table 14. Veterinary Active Pharmaceutical Ingredients Manufacturing Capacity of Major Manufacturers and Future Plan_x000D_
Table 15. China Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022_x000D_
Table 16. China Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022_x000D_
Table 17. China Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity by Company, 2018-2023, Ranked by Data of 2022_x000D_
Table 18. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)_x000D_
Table 19. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Production by Region, 2018-2023, (Tons)_x000D_
Table 20. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Production Forecast by Region, 2024-2029, (Tons)_x000D_
Table 21. Global Key Players of Veterinary Active Pharmaceutical Ingredients Manufacturing Upstream (Raw Materials)_x000D_
Table 22. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Customers_x000D_
Table 23. Veterinary Active Pharmaceutical Ingredients Manufacturing Typical Distributors_x000D_
Table 24. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_
Table 25. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_
Table 26. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018 VS 2022 VS 2029, US$ Million_x000D_
Table 27. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million_x000D_
Table 28. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Table 29. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_
Table 30. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million_x000D_
Table 31. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2018-2029_x000D_
Table 32. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Table 33. By Country, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2018-2029_x000D_
Table 34. Alivira Animal Health Ltd. Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 35. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 36. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 37. Alivira Animal Health Ltd. Company Profile and Main Business_x000D_
Table 38. Alivira Animal Health Ltd. Recent Developments_x000D_
Table 39. Excel Industries Ltd. Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 40. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 41. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 42. Excel Industries Ltd. Company Profile and Main Business_x000D_
Table 43. Excel Industries Ltd. Recent Developments_x000D_
Table 44. Ofichem Group Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 45. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 46. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 47. Ofichem Group Company Profile and Main Business_x000D_
Table 48. Ofichem Group Recent Developments_x000D_
Table 49. Chempro Pharma Private Ltd. Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 50. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 51. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 52. Chempro Pharma Private Ltd. Company Profile and Main Business_x000D_
Table 53. Chempro Pharma Private Ltd. Recent Developments_x000D_
Table 54. Menadiona Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 55. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 56. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 57. Menadiona Company Profile and Main Business_x000D_
Table 58. Menadiona Recent Developments_x000D_
Table 59. SUANFARMA Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 60. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 61. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 62. SUANFARMA Company Profile and Main Business_x000D_
Table 63. SUANFARMA Recent Developments_x000D_
Table 64. Vetpharma (Insud Pharma, S.L.U) Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 65. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 66. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 67. Vetpharma (Insud Pharma, S.L.U) Company Profile and Main Business_x000D_
Table 68. Vetpharma (Insud Pharma, S.L.U) Recent Developments_x000D_
Table 69. Siflon Drugs Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 70. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 71. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 72. Siflon Drugs Company Profile and Main Business_x000D_
Table 73. Siflon Drugs Recent Developments_x000D_
Table 74. Qilu Pharma Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 75. Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 76. Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 77. Qilu Pharma Company Profile and Main Business_x000D_
Table 78. Qilu Pharma Recent Developments_x000D_
Table 79. FIS - Fabbrica Italiana Sintetici S.p.A. Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 80. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Models, Specifications, and Application_x000D_
Table 81. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023_x000D_
Table 82. FIS - Fabbrica Italiana Sintetici S.p.A. Company Profile and Main Business_x000D_
Table 83. FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments_x000D_
List of Figures_x000D_
Figure 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Picture_x000D_
Figure 2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, (US$ million) & (2018-2029)_x000D_
Figure 3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, (Tons) & (2018-2029)_x000D_
Figure 4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP), (2018-2029) & (US$/Ton)_x000D_
Figure 5. China Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, (US$ million) & (2018-2029)_x000D_
Figure 6. China Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity (Tons) & (2018-2029)_x000D_
Figure 7. China Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP), (US$/Ton) & (2018-2029)_x000D_
Figure 8. By Consumption Value, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share of Global, 2018-2029_x000D_
Figure 9. By Sales Quantity, China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share of Global, 2018-2029_x000D_
Figure 10. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022_x000D_
Figure 11. China Veterinary Active Pharmaceutical Ingredients Manufacturing Key Participants, Market Share, 2022_x000D_
Figure 12. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Capacity, Production and Capacity Utilization, 2018-2029_x000D_
Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Capacity Market Share by Region, 2022 VS 2029_x000D_
Figure 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Production Market Share & Forecast by Region, 2018-2029_x000D_
Figure 15. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain_x000D_
Figure 16. Veterinary Active Pharmaceutical Ingredients Manufacturing Procurement Model_x000D_
Figure 17. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Model_x000D_
Figure 18. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Channels, Direct Sales, and Distribution_x000D_
Figure 19. Antiparasitic_x000D_
Figure 20. Anti-infectives_x000D_
Figure 21. NSAIDs_x000D_
Figure 22. Others_x000D_
Figure 23. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million_x000D_
Figure 24. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2018-2029_x000D_
Figure 25. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 26. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2018-2029_x000D_
Figure 27. By Type, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP), 2018-2029, (US$/Ton)_x000D_
Figure 28. Companion Animals_x000D_
Figure 29. Production/Food Animals_x000D_
Figure 30. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value, 2018-2029, US$ Million_x000D_
Figure 31. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2018-2029_x000D_
Figure 32. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 33. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2018-2029_x000D_
Figure 34. By Application, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Selling Price (ASP), 2018-2029, (US$/Ton)_x000D_
Figure 35. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2018-2029_x000D_
Figure 36. By Region, Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2018-2029_x000D_
Figure 37. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 38. By Country, North America Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022_x000D_
Figure 39. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 40. By Country, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022_x000D_
Figure 41. Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 42. By Country/Region, Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022_x000D_
Figure 43. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 44. By Country, South America Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value Market Share, 2022_x000D_
Figure 45. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 46. U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 47. By Type, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 48. By Application, U.S. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 49. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 50. By Type, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 51. By Application, Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 52. China Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 53. By Type, China Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 54. By Application, China Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 55. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 56. By Type, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 57. By Application, Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 58. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 59. By Type, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 60. By Application, South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 61. Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 62. By Type, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 63. By Application, Southeast Asia Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 64. India Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 65. By Type, India Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 66. By Application, India Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 67. Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity, 2018-2029, (Tons)_x000D_
Figure 68. By Type, Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 69. By Application, Middle East & Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 70. Research Methodology_x000D_
Figure 71. Breakdown of Primary Interviews_x000D_
Figure 72. Bottom-up and Top-down Approaches_x000D_
Figure 73. Top-down Approaches_x000D_
_x000D_
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|